Results 201 to 210 of about 210,600 (305)
Younger women with esophageal carcinoma exhibit improved prognosis after esophagectomy: a single-center, high-volume cohort study. [PDF]
Liu L +9 more
europepmc +1 more source
PHF1 is a known epigenetic regulator involved in transcriptional silencing in cancer. In this study, we identified PHF1 as an oncogene that promotes PDAC progression and demonstrated that its inhibition induces ferroptosis. Mechanistically, PHF1 physically interacts with the FBL/NOP56/NOP58 snoRNP complex to enhance the IRES‐dependent translation of ...
Yujiao Xie +9 more
wiley +1 more source
Comparison of the efficacy of different treatments after non-curative endoscopic resection of superficial esophageal carcinoma: a meta-analysis. [PDF]
Wang R, Peng LJ, Tian SN.
europepmc +1 more source
ABSTRACT Objective To investigate the impact of different radiation fields on the risk of otitis media with effusion (OME) in nasopharyngeal carcinoma (NPC) patients and to develop a nomogram to identify high‐risk patients after radiotherapy. Methods Clinical data were collected from 170 NPC patients who underwent radiotherapy at Peking Union Medical ...
Zhi‐Jin Han +11 more
wiley +1 more source
Ferroptosis: A critical link to treatment resistance in esophageal carcinoma. [PDF]
Tang MX, Chen JF, Zhao FZ, Peng J.
europepmc +1 more source
ABSTRACT Objectives Acquired cholesteatoma is an abnormal and invasive growth of keratinized squamous epithelial cells in the middle ear. The study aims to explore the role of exosomal miRNAs in the pathogenesis of acquired cholesteatoma and their potential in clinical application.
Qi Tang +12 more
wiley +1 more source
A Rare Pulmonary Complication of Esophageal Carcinoma: A Case of an Acquired Esophago-Pulmonary Fistula. [PDF]
Jesica S +3 more
europepmc +1 more source
ABSTRACT Objectives Angiopoietin‐2 (ANGPT2) is known to participate in tumor progression and immune modulation across multiple malignancies. Nevertheless, its expression pattern, prognostic value, and biological function in thyroid cancer (THCA) have not been comprehensively investigated.
Han Chen +5 more
wiley +1 more source
Immune-Related Esophagitis and Durable Response to Second-Line Treatment With Nivolumab in Stage IV Squamous Cell Esophageal Carcinoma. [PDF]
Meneses O +4 more
europepmc +1 more source
Corrigendum to: Magnolol promotes the autophagy of esophageal carcinoma cells by upregulating HACE1 gene expression. [PDF]
Huang K, Zhang B, Feng Y, Ma H.
europepmc +1 more source

